Impact of ulinastatin on survival and lymphocyte apoptosis in septic mice: Impact of ulinastatin on survival and lymphocyte apoptosis in septic mice

[1]  T. Iwaya,et al.  Influence of a Human Protease Inhibitor on Surgical Stress Induced Immunosuppression , 2012, Digestive Surgery.

[2]  E. Carrol.  Comment on “IL-15 Prevents Apoptosis, Reverses Innate and Adaptive Immune Dysfunction, and Improves Survival in Sepsis” and Comment on “IL-7 Promotes T Cell Viability, Trafficking, and Functionality and Improves Survival in Sepsis” , 2010, The Journal of Immunology.

[3]  R. Hotchkiss,et al.  Immunotherapy for sepsis--a new approach against an ancient foe. , 2010, The New England journal of medicine.

[4]  Jingyan Han,et al.  Caveolin-1 Protects against Sepsis by Modulating Inflammatory Response, Alleviating Bacterial Burden, and Suppressing Thymocyte Apoptosis* , 2010, The Journal of Biological Chemistry.

[5]  R. Hotchkiss,et al.  IL-7 Promotes T Cell Viability, Trafficking, and Functionality and Improves Survival in Sepsis , 2010, The Journal of Immunology.

[6]  H. Takano,et al.  Urinary trypsin inhibitor as a therapeutic option for endotoxin-related inflammatory disorders , 2010, Expert opinion on investigational drugs.

[7]  T. Maekawa,et al.  Urinary trypsin inhibitor suppresses excessive generation of superoxide anion radical, systemic inflammation, oxidative stress, and endothelial injury in endotoxemic rats , 2010, Inflammation Research.

[8]  C. Coopersmith,et al.  IL-15 Prevents Apoptosis, Reverses Innate and Adaptive Immune Dysfunction, and Improves Survival in Sepsis , 2009, The Journal of Immunology.

[9]  P. Charlton,et al.  VX-166: a novel potent small molecule caspase inhibitor as a potential therapy for sepsis , 2009, Critical care.

[10]  Xin-ru Liu,et al.  A metabonomic approach to early prognostic evaluation of experimental sepsis by 1H NMR and pattern recognition , 2009, NMR in biomedicine.

[11]  J. Lang,et al.  Lymphocytes, apoptosis and sepsis: making the jump from mice to humans , 2009, Critical care.

[12]  Xin-ru Liu,et al.  A metabonomic approach to early prognostic evaluation of experimental sepsis. , 2008, The Journal of infection.

[13]  S. Sriskandan,et al.  The immunology of sepsis , 2008, The Journal of pathology.

[14]  J Perren Cobb,et al.  Surviving sepsis: bcl-2 overexpression modulates splenocyte transcriptional responses in vivo. , 2007, American journal of physiology. Regulatory, integrative and comparative physiology.

[15]  M. Gaub,et al.  Transient Bcl-2 gene down-expression in circulating mononuclear cells of severe sepsis patients who died despite appropriate intensive care , 2004, Intensive Care Medicine.

[16]  R. Hotchkiss,et al.  Role of Apoptotic Cell Death in Sepsis , 2003, Scandinavian journal of infectious diseases.

[17]  R. Hotchkiss,et al.  Caspase inhibitors improve survival in sepsis: a critical role of the lymphocyte , 2000, Nature Immunology.

[18]  T. Itoh,et al.  Ulinastatin attenuates reperfusion injury in the isolated blood-perfused rabbit heart. , 2000, The Annals of thoracic surgery.

[19]  E. Medina.  Murine model of polymicrobial septic peritonitis using cecal ligation and puncture (CLP). , 2010, Methods in molecular biology.

[20]  A. Hoeft,et al.  Low serum α‐tocopherol and selenium are associated with accelerated apoptosis in severe sepsis , 2008 .